Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 153 results for "pterostilbene"

NeutriSci Announces Memorandum of Understanding Establishing a...

VANCOUVER, BC This JV will test and develop cannabinoid formulations based on NeutriSci's proprietary sublingual pterostilbene zero-sugar tablet formula and form factor; combining Lexaria's patented technology which improves the bioavailability ... Yahoo! Canada, 1 month ago
[x]  

4 images for pterostilbene

TechCrunch, 2 days ago
MDPI, 2 months ago
Freshnews.com, 3 months ago
Molecular Nutrition and Food Research, 4 months ago
TechCrunch

A new lawsuit alleges anti-aging startup Elysium Health hasn't paid its sole supplier

Chromadex, the sole supplier of pterostilbene and Nicotinamide Riboside (NR), the two ingredients in anti-aging startup Elysium's products, is suing Elysium Health for failure to make payments on those ingredients and for breach of a trademark and ...
 Yunjuu.com3 days ago
[x]  

Pterostilbene Market Opportunities and Development Forecast 2016-2021

(Before It's News) Pterostilbene Market size is projected to experience significant growth prospects from 2016 to 2021. The objective of this report is to provide a detailed analysis of the Pterostilbene industry and its impact based on ...
 Before It's News2 months ago
MDPI

IJMS, Vol. 17, Pages 1927: Pterostilbene Inhibits Human Multiple Myeloma Cells via ERK1/2 and JNK Pathway In Vitro and In Vivo

Open Access Article Int. J. Mol. Sci. 2016 , 17 (11), 1927; doi:10.3390/ijms17111927 (registering DOI) Bingqian Xie 1,† , Zhijian Xu 2,† , Liangning Hu 1,† , Gege Chen 1 , Rong Wei 1 , Guang Yang 1 ...
 MDPI2 months ago

LEXARIA BIOSCIENCE CORP : Lexaria and NeutriSci Announce Successful Cannabinoid Tablet Development and Positive Results from Initial Human Observational Trials

/ Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") and NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX-V: NU, Frankfurt-1N9) are pleased to announce the successful development and initial trial of the ...
 4 Traders14 hours ago LEXARIA AND NEUTRISCI ANNOUNCE SUCCESSFUL CANNABINOID TABLET DEVELOPMENT AND POSITIVE RESULTS(LXRP) Jan 19, 2017 9:11 AM  Investors Hub13 hours ago LEXARIA BIOSCIENCE CORP : Lexaria Enters Memorandum of Understanding Establishing a Joint Venture with NeutriSci International Inc.  4 Traders1 month ago Lexaria Enters Memorandum of Understanding Establishing a Joint Venture with NeutriSci International Inc.  TheNewswire.ca1 month ago
[x]  

7 Best Foods for People Who Have Been Diagnosed With Cancer

(Before It's News) by Twain Yobra, Natural News : Being diagnosed with cancer is one of the worst things that can happen to anyone. Most people don't know what do after theyve been diagnosed with this deadly disease. Well, changing diet is one ...
 Before It's News6 days ago

CHROMADEX CORPORATION (NASDAQ:CDXC) Files An 8-K Other Events

Item 8.01 Other Events. On December 29, 2016, ChromaDex, Inc. (ChromaDex) filed a complaint (the Complaint) in the United States District Court for the Central District of California, naming Elysium Health, Inc. as defendant. Among other ...
 4 Traders1 week ago CHROMADEX CORP. : Other Events, Financial Statements and Exhibits (form 8-K)  4 Traders1 week ago
EuroInvestor

ChromaDex Opens New State-of-the-Art Research and Development Center in Longmont

IRVINE, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Today, ChromaDex Corporation () (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients that creates science-based solutions for dietary supplement, food and beverage, ...
 Benzinga.com2 weeks ago CHROMADEX : Opens New State-of-the-Art Research and Development Center in Longmont  4 Traders1 week ago ChromaDex, Inc. Opens New State-of-the-Art Research And Development Center In Longmont  BioSpace2 weeks ago
[x]  

Critics Blast Star-Studded Advisory Board of Anti-Aging Company

Critics are assailing seven Nobel Prize winners and two dozen other high-profile scientists for lending their names and images to a New York supplement company selling an anti-aging pill. The company, Elysium Health, was startedtwo years ago to ...
 Technology Review1 week ago
EuroInvestor

ChromaDex to Present at the ICR Conference 2017 on January 11, 2017

IRVINE, Calif., Jan. 04, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), an innovator of proprietary health, wellness and nutritional ingredients, that creates science-based solutions for dietary supplement, food and beverage, skin care, ...
 4 Traders2 weeks ago ChromaDex to Present at the 3rd Annual Bernstein Consumer Summit on December 8, 2016  4 Traders1 month ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less